Guardant Health (NASDAQ: GH) insider plans August sale of 116 shares

Rhea-AI Filing Summary

Musa Tariq filed a notice to sell 116 shares of Guardant Health, Inc. common stock through Charles Schwab & Co., Inc., with an aggregate market value of $18,148.00, on or after August 17, 2026 on NASDAQ. The shares arise from a Restricted Stock Lapse tied to equity compensation that occurred on July 15, 2026. The filing also lists prior sales of Guardant Health common stock over the past three months.

Key Figures

Proposed shares to be sold: 116 shares Aggregate market value of proposed sale: $18,148.00 Proposed sale date: 08/17/2026 +5 more

8 metrics

Proposed shares to be sold 116 shares Guardant Health, Inc. common stock to be sold on or after August 17, 2026

Aggregate market value of proposed sale $18,148.00 Value of 116 Guardant Health, Inc. common shares in planned Form 144 sale

Proposed sale date 08/17/2026 Planned NASDAQ sale date for 116 Guardant Health, Inc. shares

Restricted Stock Lapse date 07/15/2026 Date the 116 equity compensation shares vested via Restricted Stock Lapse

Shares sold on May 18, 2026 11131 shares Past three-month sale of Guardant Health, Inc. common stock by Musa Tariq

Shares sold on June 16, 2026 15102 shares Past three-month sale of Guardant Health, Inc. common stock by Musa Tariq

Shares sold on June 22, 2026 255893 shares Past three-month sale of Guardant Health, Inc. common stock by Musa Tariq

Shares sold on July 16, 2026 18941 shares Past three-month sale of Guardant Health, Inc. common stock by Musa Tariq

Key Terms

Form 144, Restricted Stock Lapse, Equity Compensation, Securities To Be Sold

4 terms

Form 144 regulatory

"144: Securities Information Common | Charles Schwab & Co., Inc."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Lapse financial

"Common | 07/15/2026 | Restricted Stock Lapse | Guardant Health, Inc."

Equity Compensation financial

"116 | 07/15/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 07/15/2026 | Restricted Stock Lapse"

FAQ

What does Guardant Health (GH) disclose in this Form 144 filing?

The filing reports that Musa Tariq intends to sell 116 shares of Guardant Health, Inc. common stock with an aggregate market value of $18,148.00, to be sold through Charles Schwab & Co., Inc. on or after August 17, 2026.

How many Guardant Health (GH) shares are proposed to be sold by Musa Tariq?

Musa Tariq proposes to sell 116 shares of Guardant Health, Inc. common stock. These shares have a disclosed aggregate market value of $18,148.00 and are expected to be sold on or after August 17, 2026 through Charles Schwab & Co., Inc.

What is the value of the Guardant Health (GH) shares in this planned sale?

The proposed sale covers Guardant Health, Inc. common stock with an aggregate market value of $18,148.00. This amount corresponds to 116 shares that Musa Tariq plans to sell on or after August 17, 2026 via Charles Schwab & Co., Inc.

What is the origin of the Guardant Health (GH) shares being sold by Musa Tariq?

The 116 shares of Guardant Health, Inc. common stock come from a Restricted Stock Lapse on July 15, 2026. The transaction is described as arising from Equity Compensation, indicating the shares were originally issued as part of compensation.

What prior Guardant Health (GH) share sales by Musa Tariq are disclosed?

The filing lists past three-month sales of Guardant Health, Inc. common stock by Musa Tariq, including transactions dated May 18, 2026, June 16, 2026, June 22, 2026, and July 16, 2026, each with specific share amounts reported for those dates.

On which market will the Guardant Health (GH) shares be sold according to this notice?

The notice states that the 116 shares of Guardant Health, Inc. common stock are to be sold on NASDAQ. Charles Schwab & Co., Inc. is listed as the broker handling the sale with an aggregate market value of $18,148.00 for the proposed transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 05:05 PM Accepted by SEC EDGAR 08/17/2026 - 05:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	116	18148.00	134196170	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/15/2026	Restricted Stock Lapse	Guardant Health, Inc.			116	07/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	05/18/2026	116	11131.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/16/2026	116	15102.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/22/2026	1951	255893.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	07/16/2026	116	18941.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)